134 results
Page 4 of 7
425
o4e9pqj8vkb8qyl6
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.1
ykjtb3x
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
seinnpg7j5k b94
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.2
app3ghdk7hr3
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
riyawmxa0mmxl0ip
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
S-3ASR
EX-4.2
9ykq 1ryr
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
EX-4.2
xmcqqm14x322
20 Apr 20
Automatic shelf registration
4:55pm
D
848quwb6bgawl
13 Apr 20
$19.68M in equity, sold $19.68M, 5 investors
12:00am
D
hkhqt uly
13 Apr 20
$52.37M in equity, sold $52.37M, 58 investors
12:00am
S-3ASR
EX-4.2
j2ekvhz4c42t3
18 Mar 20
Automatic shelf registration
10:00pm
S-3ASR
EX-4.2
e7dfszz21lkw
18 Nov 19
Automatic shelf registration
5:18pm
8-K
EX-4.1
ad339e30pplr
11 Sep 19
Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes
4:07pm